Arcturus Therapeutics (ARCT)
Develops mRNA medicines for rare diseases and a CSL-partnered COVID-19 vaccine.
$13.78
vs last close−0.60 (−4.17%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
in 47 days
EPS estimate
−$0.67
Revenue estimate
$8.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$1.11−$0.52−$0.34−$0.49−$1.03−$0.95−$0.84Pending
Estimate−$0.33−$1.58−$0.89−$0.80−$0.92−$1.03−$1.00−$0.67
Surprise−236.4%+67.1%+61.9%+38.7%−12.0%+7.4%+15.7%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$22.8M$29.4M$28.3M$17.2M$7.2M$2.1M$3.0MPending
Estimate$39.9M$23.4M$18.8M$16.0M$15.9M$6.3M$3.1M$8.0M
Surprise−43.0%+25.8%+50.3%+7.0%−54.7%−67.3%−4.8%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.70 | — | — |
| Sep 2027 | −$0.86 | — | — |
| Jun 2027 | −$0.95 | — | — |
| Mar 2027 | −$0.97 | — | — |
| Dec 2026 | −$0.89 | — | — |
| Nov 2026 | −$0.67 | — | — |
| Aug 2026 | −$1.00 | −$0.84 | +15.7% |
| May 2026 | −$1.03 | −$0.95 | +7.4% |
| Mar 2026 | −$0.92 | −$1.03 | −12.0% |
| Nov 2025 | −$0.80 | −$0.49 | +38.7% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Oct 2018 | |||
| Apr 2018 | |||
| May 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.70 | — | — | $13.2M | — | — | — |
| Sep 2027 | −$0.86 | — | — | $5.4M | — | — | — |
| Jun 2027 | −$0.95 | — | — | $2.1M | — | — | — |
| Mar 2027 | −$0.97 | — | — | $3.4M | — | — | — |
| Dec 2026 | −$0.89 | — | — | $5.0M | — | — | — |
| Nov 9, 2026 | −$0.67 | — | — | $8.0M | — | — | — |
| Aug 6, 2026 | −$1.00 | −$0.84 | +15.7% | $3.1M | $3.0M | −4.8% | +21.9% |
| May 7, 2026 | −$1.03 | −$0.95 | +7.4% | $6.3M | $2.1M | −67.3% | +3.6% |
| Mar 3, 2026 | −$0.92 | −$1.03 | −12.0% | $15.9M | $7.2M | −54.7% | −4.2% |
| Nov 10, 2025 | −$0.80 | −$0.49 | +38.7% | $16.0M | $17.2M | +7.0% | −1.3% |
| Aug 11, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 6, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 5, 2024 | |||||||
| May 8, 2024 | |||||||
| Mar 7, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 7, 2023 | |||||||
| May 9, 2023 | |||||||
| Mar 28, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 9, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 8, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 10, 2021 | |||||||
| Mar 1, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 7, 2020 | |||||||
| Mar 11, 2020 | |||||||
| Nov 7, 2019 | |||||||
| Aug 15, 2019 | |||||||
| May 13, 2019 | |||||||
| Mar 18, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Oct 1, 2018 | |||||||
| Apr 2, 2018 | |||||||
| May 14, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Aug 11, 2017 | |||||||
| May 30, 2017 | |||||||
| Feb 15, 2017 | |||||||
| Nov 15, 2016 | |||||||
| Aug 30, 2016 | |||||||
| May 16, 2016 | |||||||
| Feb 17, 2016 | |||||||
| Nov 12, 2015 | |||||||
| Aug 13, 2015 |